LGC Biosearch Technologies A/S — Credit Rating and Financial Key Figures
CVR number: 34884900
Sønderskovvej 5, 8520 Lystrup
Income statement (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | 41.82 | 103.81 | 101.48 | 118.03 | 105.58 |
Other operating income | 2.17 | 3.07 | 3.98 | 1.41 | 2.37 |
Purchases during the financial year | -9.62 | -19.50 | -28.68 | -29.52 | -32.67 |
External services | -11.13 | -16.46 | -26.24 | -29.86 | -29.03 |
Gross profit | 23.23 | 70.92 | 50.54 | 60.05 | 46.25 |
Employee benefit expenses | -12.22 | -17.63 | -26.35 | -34.72 | -31.88 |
Other operating expenses | -1.50 | -0.31 | |||
Total depreciation | -2.66 | -3.68 | -6.67 | -9.91 | -10.88 |
EBIT | 8.35 | 48.11 | 17.21 | 15.42 | 3.49 |
Other financial income | 0.01 | 0.20 | |||
Other financial expenses | -0.31 | -0.24 | -1.15 | -0.62 | -0.40 |
Pre-tax profit | 8.04 | 47.86 | 16.07 | 14.82 | 3.30 |
Income taxes | -12.27 | -3.46 | -3.08 | -0.74 | |
Net earnings | 8.04 | 35.59 | 12.61 | 11.73 | 2.56 |
Assets (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 0.78 | 0.69 | |||
Goodwill | 5.67 | 4.94 | 4.22 | 3.49 | 2.77 |
Intangible assets total | 5.67 | 4.94 | 4.22 | 4.27 | 3.46 |
Buildings | 0.72 | 0.38 | 13.64 | 13.79 | 13.21 |
Machinery and equipment | 8.53 | 12.16 | 31.10 | 27.68 | 27.12 |
Advance payments and construction in progress | 0.30 | 0.30 | 0.30 | 0.30 | |
Tangible assets total | 9.55 | 12.84 | 45.04 | 41.77 | 40.33 |
Other receivables | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
Investments total | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
Long term receivables total | |||||
Raw materials and consumables | 3.45 | 6.95 | 12.32 | 18.03 | 18.44 |
Inventories total | 3.45 | 6.95 | 12.32 | 18.03 | 18.44 |
Current trade debtors | 7.15 | 16.64 | 10.82 | 17.77 | 6.38 |
Current amounts owed by group member comp. | 0.24 | 0.62 | 0.99 | 1.09 | 5.83 |
Prepayments and accrued income | 0.93 | 1.06 | 2.58 | 5.21 | 4.87 |
Current other receivables | 0.32 | 2.29 | 2.07 | 1.28 | 0.78 |
Current deferred tax assets | 2.04 | 2.06 | 2.67 | ||
Short term receivables total | 10.68 | 20.62 | 18.53 | 25.34 | 20.52 |
Cash and bank deposits | 4.31 | 28.35 | 7.16 | 13.66 | 16.54 |
Cash and cash equivalents | 4.31 | 28.35 | 7.16 | 13.66 | 16.54 |
Balance sheet total (assets) | 33.97 | 74.01 | 87.58 | 103.38 | 99.60 |
Equity and liabilities (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
Retained earnings | 8.85 | 16.88 | 52.48 | 65.08 | 76.81 |
Profit of the financial year | 8.04 | 35.59 | 12.61 | 11.73 | 2.56 |
Shareholders equity total | 17.38 | 52.98 | 65.58 | 77.31 | 79.87 |
Provisions | 1.67 | 2.17 | 1.44 | 1.58 | |
Non-current owed to group member | 6.19 | ||||
Non-current other liabilities | 0.76 | ||||
Non-current liabilities total | 6.95 | ||||
Current trade creditors | 1.73 | 1.89 | 8.53 | 4.72 | 11.66 |
Current owed to group member | 1.33 | 1.97 | 4.69 | 10.19 | 2.14 |
Short-term deferred tax liabilities | 3.56 | 2.39 | |||
Other non-interest bearing current liabilities | 6.58 | 11.94 | 5.58 | 7.33 | 4.35 |
Accruals and deferred income | 1.02 | ||||
Current liabilities total | 9.64 | 19.36 | 19.83 | 24.63 | 18.15 |
Balance sheet total (liabilities) | 33.97 | 74.01 | 87.58 | 103.38 | 99.60 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.